Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024Participation in the CPhI Worldwide 2018
Our company had the pleasure to participate in the world’s largest pharmaceutical exhibition, CPhI Worldwide on 9-11 October 2018 in Madrid.
For the first time in our history, we were honored to participate in such a large-scale worldwide exhibition. Our Member of the board Dr. Polina Dombure made a presentation about "CIS Market: Regulatory Strategies in Dynamic Convergence", also including a presentation about Prudenta, a solution for monitoring adverse drug reactions in the local medical literature.
CPhI Worldwide houses six individual pharma events covering all industry sectors. We can not disagree that CPhI is uniting over 45,000 pharma professionals from around the globe and more than 2,500 international exhibitors and it is the place to network and source cost-effective pharma solutions from all over the world. In just three days under one roof, we had a chance to connect & network with international exhibitors and pharma professionals.
See you in Frankfurt next time!
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024Особенности процедуры пользовательского тестирования листка-вкладыша в Казахстане
May 28, 2024Peculiarities of PIL Readability User Testing Procedure in Kazakhstan
May 28, 2024Требования к клиническим испытаниям при регистрации медицинских изделий в России
May 21, 2024Clinical Trials Requirements for Medical Device Registration in Russia
May 21, 2024Команда Inpharmatis приняла участие в конференции RAPS Euro Convergence 2024
May 10, 2024Inpharmatis Team Participated in RAPS Euro Convergence 2024
May 10, 2024